BETALIN THERAPEUTICS
Betalin Therapeutics is a privately-held company. We develop a cell therapy solution for insulin-dependent diabetes, an Engineered Micro-Pancreas (EMP). The EMP is a combination of harvested pancreatic islets (also known as Islets of Langerhans) and a proprietary biological micro-environment for supporting the harvested cells. After promising in-vitro results and preliminary in-vivo results, Betalin Therapeutics is currently putting efforts to further optimize the therapy in animal models, complete submission of the Investigational New Drug (IND) application to the FDA, and proceed to clinical trials.
BETALIN THERAPEUTICS
Industry:
Biotechnology Health Care Wellness
Founded:
2015-07-01
Address:
Ramat Gan, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.betalintherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+972779400370
Email Addresses:
[email protected]
Total Funding:
5.75 M USD
Technology used in webpage:
Google Maps GoDaddy
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Inceptor Bio
Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Pandion Therapeutics
Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.
Current Employees Featured
Founder
Investors List
European Innovation Council
European Innovation Council investment in Venture Round - Betalin Therapeutics
European Innovation Council
European Innovation Council investment in Grant - Betalin Therapeutics
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Seed Round - Betalin Therapeutics
Official Site Inspections
http://www.betalintherapeutics.com Semrush global rank: 13.32 M Semrush visits lastest month: 78
- Host name: 90.20.180.107.host.secureserver.net
- IP address: 107.180.20.90
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Betalin Therapeutics"
BETALIN – Liberating from Insulin Dependency
[email protected]; Jerusalem Bio Park (JBP), Minrav Bldg, 1st Floor, Hadassah Ein Keren Campus, Jerusalem, Israel. Accessibility Toolbar. close Toggle the visibility of the …See details»
Betalin Therapeutics - Crunchbase Company Profile
Sub-Organization of . Yissum Technology Transfer Company of the Hebrew University . Founded Date Jul 2015; Founders Shay Hershcovich, Shuki …See details»
Betalin Therapeutics Ltd. | LinkedIn
Betalin Therapeutics Ltd. | 1,820 followers on LinkedIn. Liberating from Insulin Dependency | Over 537 million diabetic people suffer daily from managing the disease, which may require multiple ...See details»
Betalin Therapeutics - Israeli Startup | Startup Nation …
Jul 21, 2021 Work Email* (please provide your email in the organization) Position* Notes. Send Create Free Account. Create Free Account. 8 Characters, Uppercase letter (A-Z), Lowercase letter (a-z), Digit ...See details»
Betalin Therapeutics - European Commission
Betalin Therapeutics is developing the next generation of insulin-producing cell transplantation providing a solution for insulin-dependent diabetic people using tissue engineering.See details»
Betalin Therapeutics 2025 Company Profile: Valuation, Funding ...
Betalin Therapeutics General Information Description. Developer of cell therapy platform designed to focus on creating insulin therapy alternatives. The company uses technology to create …See details»
Betalin Therapeutics Company Profile | Management and
Www.betalintherapeutics.com . Betalin Therapeutics Profile and History. Established in 2015, Betalin Therapeutics is developing a biological micro pancreas implanted with human-source …See details»
BETALIN THERAPEUTICS LTD - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for BETALIN THERAPEUTICS LTD of JERUSALEM, Jerusalem Area. Get the latest business insights from …See details»
Betalin Therapeutics - JLM-BioCity
Betalin TherapeuticsCEO: Shay HerchcoviciYear Established: 2015Betalin Therapeutics is developing an innovative and breakthrough therapy for diabetes treatment. This game …See details»
EU Tech Fund Invests in Betalin Therapeutics …
Feb 22, 2022 The European Innovation Council (EIC) Fund has decided to make a direct equity investment in Jerusalem-based Betalin Therapeutics in the amount of 500,000 Euros. The investment is intended to fund its flagship …See details»
BETALIN THERAPEUTICS LTD - VentureRadar
Similar Companies: Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, …See details»
Betalin Therapeutics Ltd.: Contact Details and Business Profile
Betalintherapeutics.com; 1 97250728XXXX; Zohar Pinhasi Member Board Of Directors at Betalin Therapeutics Ltd. Hollywood, FL, US View. 3 monstercloud.com; gopcusa.com; …See details»
BETALIN THERAPEUTICS LTD - VentureRadar
Website: http://www.betalintherapeutics.com/ Betalin Therapeutics Ltd is a preclinical stage company developing an innovative and breakthrough therapy for diabetes ...See details»
Betalin Therapeutics - 2025 Company Profile - Tracxn
Mar 28, 2025 Betalin Therapeutics - Developing engineered micro-pancreas (EMP) for diabetes treatment. Raised a total funding of $6M over 7 rounds from 3 investors. Founded by Shay …See details»
Betalin Therapeutics - explore.openaire.eu
Organization, country, Betalin Therapeutics, BETALIN THERAPEUTICS LTDSee details»
Betalin Therapeutics - 972VC
Worldwide, 387 million people suffer from diabetes (WHO, 2015). Of these, 153 million people are treated with insulin injections, $24B annual revenues. To provide an effective treatment for …See details»
Possible diabetes cure from HU research moves closer to clinical …
Nov 12, 2019 The global Type 1 diabetes market is expected to be worth $25.52 billion by 2024. The World Health Organization estimates that nearly half a billion people worldwide suffer from …See details»
Betalin Therapeutics Company Information - Funding, Investors, …
Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»
Betalin Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...
Www.betalintherapeutics.com. Last update 11 Jul 2024See details»